387 Pegloticase, a recombinant urate oxidase conjugated to polyethylene glycol (PEG), has been introduced to reduce immunogenicity and extend the half-life of rasburicase
Subsequently, 0.4 mL of a PI staining/lysis solution (0.5% NP-40, 0.5 mM ethylenediaminetetraacetic acid [EDTA]) and 50 L of RNase A (10 mg/mL in TrisEDTA buffer, pH 8.0) solution were added
Me 12 500 MCG Injection is administered by a qualified health care professional in a hospital or clinic
Symptom Reduction: Many patients report a reduction in the daily pain, heaviness, and swelling of their limbs, even if the volume of the legs hasn't changed drastically
Your body maintains therapeutic levels for several days, so a 24-hour shift in timing creates only a minor gap in coverage